Dr. Christopher D. Bahl received his doctoral degree in Biochemistry from Geisel School of Medicine at Dartmouth. He had continued postdoctoral research with Dr. David Baker at the University of Washington. Dr. Bahl is currently the Head of Protein Design at the Institute of Prot More...
Research Area and Skills
Recognize this scientist’s Expertise for their contribution in your research
Buchko GW, Pulavarti SVSRK, Ovchinnikov V, et al. Cytosolic expression, solution structures, and molecular dynamics simulation of genetically encodable disulfide-rich de novo designed peptides. Protein Sci. 2018;27(9):1611-1623.
Bahl CD, St laurent JD, Karthikeyan RS, et al. The cif Virulence Factor Gene Is Present in Isolates From Patients With Pseudomonas aeruginosa Keratitis. Cornea. 2017;36(3):358-362.
Chevalier A, Silva DA, Rocklin GJ, et al. Massively parallel de novo protein design for targeted therapeutics. Nature. 2017;550(7674):74-79.
|Cat. No.||Name||Plasmid Copy||Bacterial Resistance||Growth Strain|